HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bart Staels Selected Research

Interleukin-6 (Interleukin 6)

6/2014Impact of endotoxin challenge in obese pigs.
8/2012Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
6/2008Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response.
5/2006Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
4/2004Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bart Staels Research Topics

Disease

88Inflammation (Inflammations)
11/2023 - 01/2002
65Type 2 Diabetes Mellitus (MODY)
03/2024 - 05/2002
64Atherosclerosis
12/2021 - 01/2002
52Insulin Resistance
10/2023 - 05/2002
45Obesity
03/2024 - 04/2004
44Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 02/2002
40Dyslipidemias (Dyslipidemia)
10/2023 - 03/2003
28Non-alcoholic Fatty Liver Disease
04/2024 - 08/2008
25Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2024 - 04/2004
21Fibrosis (Cirrhosis)
04/2024 - 04/2008
18Body Weight (Weight, Body)
10/2023 - 11/2007
14Fatty Liver
04/2024 - 09/2002
13Alcoholic Fatty Liver
10/2023 - 04/2006
12Metabolic Diseases (Metabolic Disease)
01/2024 - 12/2005
12Hepatocellular Carcinoma (Hepatoma)
04/2014 - 12/2002
11Hyperglycemia
01/2019 - 04/2005
10Hypertriglyceridemia
11/2021 - 02/2005
10Atherosclerotic Plaque (Atheroma)
06/2017 - 04/2007
9Neoplasms (Cancer)
10/2023 - 10/2005
9Weight Gain
03/2020 - 12/2005
8Stroke (Strokes)
03/2024 - 07/2003
7Liver Diseases (Liver Disease)
12/2023 - 12/2013
7Hypertension (High Blood Pressure)
01/2019 - 02/2002
6Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 12/2013
6Aortic Valve Stenosis (Aortic Stenosis)
11/2023 - 03/2015
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2011
6Coronary Artery Disease (Coronary Atherosclerosis)
04/2015 - 03/2002
5Glucose Intolerance
12/2022 - 04/2006
5Infections
01/2021 - 06/2008
5Hyperinsulinism (Hyperinsulinemia)
01/2018 - 09/2002
4Weight Loss (Weight Reduction)
10/2023 - 03/2015
4Ischemia
05/2021 - 05/2002
4Overweight
11/2018 - 09/2008
4Acute-Phase Reaction
06/2008 - 04/2004
3Heart Failure
01/2023 - 06/2007
3Reperfusion Injury
11/2022 - 05/2002
3Hemorrhage
01/2022 - 01/2018
3Disease Progression
01/2021 - 12/2020

Drug/Important Bio-Agent (IBA)

70Glucose (Dextrose)FDA LinkGeneric
03/2024 - 02/2002
64LipidsIBA
10/2023 - 01/2002
54Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2024 - 01/2002
47PPAR alphaIBA
11/2014 - 02/2002
30Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2023 - 09/2003
29Bile Acids and Salts (Bile Acids)IBA
06/2022 - 04/2002
28LigandsIBA
06/2022 - 05/2002
27Triglycerides (Triacylglycerol)IBA
12/2021 - 12/2002
25CholesterolIBA
10/2023 - 03/2003
24Insulin (Novolin)FDA Link
10/2023 - 05/2004
23Fibric Acids (Fibrates)IBA
12/2021 - 12/2002
21PPAR gammaIBA
11/2023 - 05/2002
14Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2002
14Transcription Factors (Transcription Factor)IBA
12/2022 - 09/2002
14Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 02/2002
14ThiazolidinedionesIBA
12/2021 - 08/2003
13CytokinesIBA
01/2023 - 01/2002
13Lipoproteins (Lipoprotein)IBA
12/2021 - 09/2002
12HDL CholesterolIBA
12/2020 - 12/2005
11Messenger RNA (mRNA)IBA
01/2022 - 02/2003
11ApolipoproteinsIBA
01/2021 - 07/2003
11Fenofibrate (CiL)FDA LinkGeneric
01/2019 - 12/2002
10LDL Receptors (LDL Receptor)IBA
01/2021 - 04/2003
9EnzymesIBA
01/2022 - 07/2003
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 10/2004
8oxidized low density lipoproteinIBA
12/2020 - 12/2006
72- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA
01/2021 - 09/2011
7HDL LipoproteinsIBA
03/2015 - 03/2003
6CollagenIBA
11/2023 - 04/2006
6LDL CholesterolIBA
01/2022 - 05/2006
6Metformin (Glucophage)FDA LinkGeneric
08/2019 - 05/2005
6Liver X ReceptorsIBA
01/2019 - 03/2003
6Apolipoprotein E2IBA
01/2016 - 04/2006
6Rosiglitazone (Avandia)FDA Link
12/2012 - 05/2002
5Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2007
5Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 03/2015
5Interleukin-6 (Interleukin 6)IBA
06/2014 - 04/2004
4Blood Glucose (Blood Sugar)IBA
01/2023 - 08/2005
4AcidsIBA
11/2022 - 05/2004
4von Willebrand FactorIBA
01/2022 - 06/2014
4Apolipoproteins E (ApoE)IBA
01/2021 - 04/2009
4LDL Lipoproteins (beta Lipoproteins)IBA
12/2020 - 05/2006
4Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2016 - 04/2002
4Cyclin-Dependent Kinase Inhibitor p16IBA
04/2015 - 11/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2014 - 05/2006
4Pioglitazone (Actos)FDA Link
03/2013 - 09/2005
4PPAR deltaIBA
04/2010 - 11/2003
4GlucocorticoidsIBA
08/2009 - 04/2003
4NF-kappa B (NF-kB)IBA
08/2008 - 01/2003
4Chenodeoxycholic Acid (Chenix)FDA Link
03/2008 - 02/2003
4GW 4064IBA
03/2008 - 02/2003
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2022 - 01/2017
3LiraglutideFDA Link
01/2022 - 01/2019
3Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2022 - 10/2005
3CalciumIBA
01/2022 - 10/2013
3Choline (Choline Chloride)IBA
01/2022 - 12/2013
3Amyloid (Amyloid Fibrils)IBA
01/2021 - 03/2014

Therapy/Procedure

28Therapeutics
04/2024 - 01/2006
5Bariatric Surgery
10/2023 - 09/2017
4Transcatheter Aortic Valve Replacement
11/2023 - 03/2015
4Gastric Bypass (Roux-en-Y Gastric Bypass)
10/2023 - 03/2015
4Drug Therapy (Chemotherapy)
02/2015 - 01/2006